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Pax7 is a key regulator of skeletal muscle stem cells and is required along with Pax3 to generate skeletal muscle
precursors. We have identiﬁed a collection of genes induced by either Pax3 or Pax7 in C2C12 muscle cells. Two notable
Pax3/7 targets are the inhibitory helix-loop-helix (HLH) proteins inhibitor of DNA binding (Id) 2 and Id3, both of which
are coordinately expressed with Pax7 in quiescent satellite cells and are induced in quiescent C2C12 myogenic cells after
ectopic expression of either Pax3 or Pax7. Ectopic Pax7 activates expression of a luciferase reporter driven by the Id3
promoter, and maximal induction of this reporter requires a conserved Pax7 binding site located upstream of the Id3 gene.
Chromatin immunoprecipitation indicated that Pax7 is bound upstream of the Id3 promoter in quiescent satellite cells. In
addition, short hairpin RNA-mediated knockdown of Pax7 expression in cultured satellite cells coordinately decreased
both Id2 and Id3 expression. Together, these ﬁndings indicate that Id3 is a direct transcriptional target for Pax7 in
quiescent satellite cells, and they suggest that Pax7 acts to block premature differentiation of quiescent satellite cells by
inducing the expression of Id2 and Id3, which in turn may act to block either the precocious induction of myogenic basic
(b)HLH proteins, the activity of myogenic bHLH proteins, or both.
INTRODUCTION
Pax3 and Pax7 are two closely related transcription factors
that are expressed in the dermomyotome, and they have
been shown to be essential for generation of all fetal trunk
musculature (Relaix et al., 2005). Pax3/7-expressing dermo-
myotomal cells have recently been shown to give rise to
skeletal muscle progenitors, termed satellite cells, in the
adult (Gros et al., 2005; Kassar-Duchossoy et al., 2005; Relaix
et al., 2005; Schienda et al., 2006). Satellite cells are a small
population of myogenic progenitors that reside between the
sarcolemma and basal lamina of the muscle ﬁber, and they
play a crucial role in postnatal muscle growth and regener-
ation (reviewed in Zammit et al., 2006). Following skeletal
muscle injury or exercise-induced activation, the normally
quiescent Pax7-expressing satellite cells proliferate exten-
sively and up-regulate expression of MyoD (Smith et al.,
2001; Yan et al., 2003; Montarras et al., 2005) and Myf-5
(Conboy and Rando, 2002; Yan et al., 2003), before differen-
tiation into skeletal muscle.
Pax3 and Pax7 are members of the Pax transcription factor
family and contain both paired (PD) and homeodomain
(HD) DNA binding motifs. Pax3 and Pax7 can bind to DNA
sequences containing either a consensus paired domain
binding site (GTCAC A/G C/G A/T T/C) or a homeodo-
main binding site (ATTA) (Chalepakis et al., 1994; Chalepakis
and Gruss, 1995). Pax3 and Pax7 activate MyoD expression
(Maroto et al., 1997; Tajbakhsh et al., 1997; Relaix et al., 2003,
2004), and recently Pax3 has been shown to directly bind
sequences that regulate the expression of either MyoD in
C2C12 cells (Hu et al., 2008) or Myf-5 during development of
hypaxial muscle (Bajard et al., 2006). Although it is clear that
Pax3/7 can directly induce the expression of Myf5 (Bajard et
al., 2006), MyoD (Hu et al., 2008), and ﬁbroblast growth
factor receptor 4 (Lagha et al., 2008), other relevant targets
for Pax3/7 in satellite cells have yet to be identiﬁed. To
identify potential targets for Pax3/7 in satellite cells, we
examined the transcriptional proﬁle of genes induced by
these transcription factors in the C2C12 muscle cell line. Of
the genes identiﬁed, we found that a subset were also ex-
pressed in quiescent satellite cells and therefore they could
potentially be direct targets of Pax7 in these cells. In this
report, we focus on two such putative Pax3/7 transcrip-
tional targets, inhibitor of DNA binding (Id) 2 and Id3,
which we found to be expressed in quiescent satellite cells.
We report that Pax3/7 can drive expression of both Id2 and
Id3 in C2C12 cells under low serum conditions, that the Id3
promoter contains a conserved Pax3/7 binding site, and that
Pax3/7 can activate expression of a reporter construct
driven by the Id3 promoter. In addition, we demonstrate
that Pax7 is normally bound to the Id3 promoter in quiescent
satellite cells and that short hairpin RNA (shRNA)-mediated
knockdown of Pax7 expression in cultured satellite cells
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gether, these ﬁndings suggest that Id2 and Id3 are both
transcriptional targets of Pax7 and that Id3 is a direct tran-
scriptional target of Pax7 in satellite cells. Because the Id
gene family contains key negative regulators of positively
acting basic helix-loop-helix (bHLH) proteins (reviewed in
Ruzinova and Benezra, 2003; Perk et al., 2005), our ﬁndings
suggest that Pax7-induced expression of Id family members
in quiescent satellite cells may act to block myogenic bHLH
function in these cells.
MATERIALS AND METHODS
Antibodies
Anti-FLAG and anti-tubulin antibodies were purchased from Sigma-Aldrich
(St. Louis, MO). Anti-hemagglutinin (HA) antibody was purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). Anti-Pax3 and anti-Pax7 anti-
bodies were obtained from Developmental Studies Hybridoma Bank (Uni-
versity of Iowa, Iowa City, IA). Anti-Id3 antibody was generously supplied by
Robert Benezra (Memorial Sloan Kettering Cancer Center, New York, NY).
Cell Culture and Transient Transfection
CSM4B cells were isolated from 2-mo-old C57BL/6 mice as described previously
(Cerletti et al., 2008). The cells were grown in F-12 media supplemented with 20%
horse serum, 50 U/ml penicillin, and 50 g/ml streptomycin. C2C12 cells were
grown in DMEM supplemented with 10% fetal bovine serum, 50 U/ml penicillin,
and 50 g/ml streptomycin. For differentiation, the media were changed to
DMEM supplemented with 2% horse serum, 50 U/ml penicillin, and 50 g/ml
streptomycin. FuGENE 6 (Roche Diagnostics, Indianapolis, IN) was used for
transient transfection per the manufacturer’s directions.
Plasmids
Mouse Pax3 (Maroto et al., 1997) or Pax7d (Seale et al., 2004) cDNAs were
polymerase chain reaction (PCR) ampliﬁed to remove stop codons and cloned
in a retroviral vector (pOZ-FH-C-puro). pOZ-FH-C-puro vector was made by
modifying the pOZ-FH-C vector (Nakatani and Ogryzko, 2003). A PCR-
ampliﬁed puromycin resistance gene (isolated from pBabe-puro) was cloned
in place of interleukin-2R using NcoI and BamHI site. pGL3-Id3(934)-
ﬁreﬂy luciferase and pGL3-Id3(517)-ﬁreﬂy luciferase were made by PCR
ampliﬁcation of mouse Id3 proximal promoter fragments 934 to 13 and
517 to 13. These fragments were then ligated to KpnI–BglII cut pGL3-basic
vector (Promega, Madison, WI). The HD and PD mutant Id3 reporters were
made by PCR mutagenesis. The HD site (AATTAA) was mutated to an XhoI
site (CTCGAG), whereas PD site (GTCACAAGAT) was mutated to create a
NheI site (TTGCTAGCCC). The lentiviral vector expressing green ﬂuorescent
protein (GFP) shRNA was obtained from Addgene (Cambridge, MA) (depos-
ited by Robert Weinberg, Massachusetts Institute of Technology, Cambridge,
MA). The lentivirus packaging vector (psPAX2) and envelope vector
(pMD2.G) were also obtained from Addgene (deposited by Didier Trono,
École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland). The len-
tiviral vector expressing Pax7 shRNA was purchased from Open Biosystems
(Huntsville, AL). The sequence of the Pax7 shRNA target site was GCTGTT-
GATTACCTGGCCAAA.
Generation of Pax3- or Pax7-expressing C2C12 Cells
Murine retroviruses expressing either Pax3 or Pax7 were made as described in
Nakatani and Ogryzko (2003). C2C12 cells were infected with either pOZ-FH-C-
puro or with pOZ-Pax3-Flag/HA-puro or pOZ-Pax7-Flag/HA-puro. Twenty-
four hours after infection, stable polyclones were selected using puromycin.
Reverse Transcriptase (RT)-PCR
RNA was harvested from samples using the RNeasy mini kit (QIAGEN,
Valencia, CA) per the manufacturer’s instructions. For semiquantitative re-
verse transcriptase-PCR, reverse transcription and PCR analysis were carried
out as described previously (Munsterberg et al., 1995). The primers used for
PCR are described in Supplemental Table 2. The RT-quantitative (q)PCR was
carried out using ABI Prism 7700 and SYBR Premix Ex Taq kit (Takara Bio
USA, Madison, WI) per the manufacturer’s instructions.
Immunostaining
Single myoﬁbers were isolated from intact limb muscle and immunostained
as described in Cerletti et al. (2008). In brief, myoﬁbers were permeabilized
with 0.2% Triton X-100 for 20 min, washed with phosphate-buffered saline,
and then blocked for 1 h with M.O.M. Ig blocking reagent (Vector Laborato-
ries, Burlingame, CA)/milk and 2% goat serum. Subsequently, myoﬁbers
were blocked with an avidin/biotin blocking kit (Vector Laboratories). The
myoﬁbers were then incubated overnight at 4°C with primary antibodies
against Pax7 (mouse anti-Pax7) and Id3 (rabbit anti-Id3). After washing, the
myoﬁbers were incubated with goat anti-mouse Alexa 594 (Invitrogen, Carls-
bad, CA) for Pax7 and biotinylated anti-rabbit IgG (Vector Laboratories)
followed by streptavidin-Alexa 488 (Invitrogen) for Id3. Nuclei were stained
with 4,6-diamidino-2-phenylindole (Vector Laboratories). Fluorescence im-
ages were acquired using an BX60 microscope with DPManager software
(Olympus Optical, Center Valley, PA).
Electrophoretic Mobility Shift Assay (EMSA)
C2C12 nuclear extract was prepared using nuclear extract preparation kit
(Active Motif, Carlsbad, CA) per the manufacturer’s instructions. To make the
probe, two complementary oligonucleotides, 5-GCTTCACCGCAATTAATTT-
TTTCCCCCTCTGGTCACAAGATAATTCCTGA-3 and 5-TCAGGAATTATC-
TTGTGACCAGAGGGGGAAAAAATTAATTGCGGTGAAGC-3, containing the
HD and PD binding element of the Id3 promoter were annealed and radiolabeled
using [-32P]dATP. The nuclear extracts were incubated with radiolabeled DNA
probe for 30 min at 25°C in a reaction mixture containing 10 mM Tris, pH 7.9, 50
mM NaCl, 2 mM MgCl2, 1 mM EDTA, 1 mM dithiothreitol, 5% glycerol (vol/
vol), and 100 ng/ml poly(dI-dC). DNA–protein complexes were fractionated in
a 6% nondenaturing polyacrylamide gel. For antibody interaction studies, nu-
clear extract was preincubated with antibody for 15 min.
Chromatin Immunoprecipitation (ChIP) Assay
ChIP with C212 cells was carried out using the ChIP assay kit (Millipore,
Billerica, MA) per the manufacturer’s directions. ChIP on isolated CSM4B
cells was performed as described in Attema et al. (2007). The immunoprecipi-
tated DNA was recovered using a PCR puriﬁcation kit (QIAGEN) and was
used as template in PCR with speciﬁc primers spanning the HD and PD
binding site of Id3 promoter. PCR products were run on 1% agarose gel and
visualized by ethidium bromide staining. Primers used for ampliﬁcation of
mouse Id3 promoter were 5-CCGGGCATACATTTAGTTCCT-3 and 5-
TCTCTCTCTCCTCTCTCTCTCTCAA-3.
RESULTS
Identiﬁcation of Pax3/7 Transcriptional Targets in C2C12
Cells
To identify the transcriptional targets of Pax3 and Pax7, we
infected C2C12 cells with either a retrovirus (pOZ-FH-C-
puro) that encodes puromycin resistance, or with retrovi-
ruses programmed to encode both puromycin resistance and
either HA/FLAG-tagged Pax3 or HA/FLAG-tagged Pax7
(pOZ-Pax3-FLAG/HA-puro or pOZ-Pax7-FLAG/HA-puro,
respectively). Puromycin-resistant polyclones of C2C12 cells
that stably expressed either Pax3 or Pax7 were selected.
Because the parental C2C12 cells used in our laboratory
express either no or only trace levels of endogenous Pax3
and Pax7 (Figure 2A), these cells are a good cellular context
to evaluate the effects of exogenous Pax3/7 expression in a
cellular background that is devoid of these proteins. We
performed DNA microarray proﬁling by using the Mouse
Expression Array 430_2.0 (Affymetrix, Santa Clara, CA) to
identify genes whose expression was induced by either or
both of these Pax genes in C2C12 cells cultured under low
serum conditions. Of a total of 39,000 genes analyzed, we
identiﬁed 156 whose expression was induced threefold or
greater by either Pax3 or Pax7 (Supplemental Table 1).
Eleven of these Pax3/7-inducible genes have been observed
previously to be induced by Pax7 in C2C12 cells (McKinnell
et al., 2008) (Supplemental Table 1). In addition, 28 of the
genes we identiﬁed were shown previously to be expressed
at higher levels in quiescent versus activated satellite cells
(Fukada et al., 2007) (Supplemental Table 1), correlating with
the greater level of expression of Pax7 in quiescent versus
activated satellite cells (Figure 1A). The HLH inhibitor Id3
was one of the genes most highly induced by Pax7 in C2C12
cells cultured in low serum, showing a 33-fold induction and
a high absolute level of expression (3168 U). Although Id2
was also induced by Pax7, Id2 displayed both a lower -fold
induction (5-fold) and a lower absolute level of expression
(542 U). Both these genes had been observed previously to
be induced by Pax7 in C2C12 cells (McKinnell et al., 2008).
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genes that we had identiﬁed in C2C12 cells were indeed
physiological targets of Pax3/7, we decided to focus our
analysis on the putative Pax3/7 target genes that were also
expressed in quiescent satellite cells, which constitutively
express endogenous Pax7. We puriﬁed CD45, Sca-1, Mac-
1, CXCR4, and -1 integrin (CSM4B) myoﬁber-associ-
ated satellite cells by ﬂuorescence-activated cell sorting
(FACS) (Cerletti et al., 2008) from the skeletal muscle of
2-mo-old mice. Greater than 90% of CSM4B cells have been
shown to express Pax7 after immediate isolation, and they
efﬁciently differentiate into skeletal muscle both in vitro and
in vivo (Cerletti et al., 2008). We assayed by RT-PCR the
expression of Id2, Id3, and some other putative Pax7 targets
that we had identiﬁed in the sorted CSM4B population. This
analysis identiﬁed several putative Pax7 target genes that
are speciﬁcally expressed in quiescent Pax7 CSM4B cells,
including Id2 and Id3, integral membrane protein 2A
(ITM2A), the chemokine receptor CXCR4, Bone Morpho-
genic Protein 4 (BMP4), the sugar binding protein chond-
rolectin, complement component 1 R subunit (C1R), pros-
taglandin I2 (prostacyclin) synthase (PTGIS), and matrix
Gla protein (MGP). RT-PCR analysis of gene expression in
immediately harvested versus cultured CSM4B cells indi-
cated that all these putative Pax7 targets are expressed in
freshly isolated CSM4B cells (which express high levels of
Pax7), and that in many cases their expression declines
during culture of these cells (Figure 1A), in parallel with
reduced Pax7 expression, induced proliferation, and even-
tual differentiation of these cells into myotubes (Cerletti et
al., 2008). Id2 and Id3 were robustly expressed in both
freshly isolated Pax7, MyoD CSM4B cells and in prolif-
erating Pax7, MyoD CSM4B cultures; expression of Id2
and Id3 declined and was eventually lost in differentiated
cultures of Pax7, MyoD CSM4B-derived myoblasts (Fig-
ure 1A, lanes 1–6). In contrast to Id2 and Id3, Id1 expression
was not detected in either freshly isolated or cultured
CSM4B cells (data not shown). Although the Id genes have
been linked previously to cellular proliferation in at least
some cellular contexts (Benezra et al., 1990), in CSM4B-
derived myoblasts Id2 and Id3 are expressed in both quies-
cent and proliferating cells, indicating that their expression
can be uncoupled from the cell cycle in this cell type.
Pax3 or Pax7 Induces the Expression of Id Family
Members in C2C12 Cells and Id3 Protein Is Detectable in
Quiescent Satellite Cells
To further analyze the ability of Pax3 or Pax7 to induce
expression of Id proteins, we evaluated expression of Id1,
Id2, and Id3 by RT-PCR in either parental C2C12 cells or in
polyclones of C2C12 cells programmed to express exoge-
nous Pax3 or Pax7. Both the parental C2C12 cells and the
Pax3/Pax7-expressing C2C12 polyclones expressed approx-
imately equivalent levels of Id1, Id2, and Id3 transcripts
when the cells were cultured under high serum conditions
(i.e., 10% fetal bovine serum) (Figure 2A, lanes 1–3). In
striking contrast, when the cells were cultured under low
serum conditions for 3 d (i.e., 2% horse serum), parental
Figure 1. Id2, Id3, and other putative Pax7 target genes are ex-
pressed in quiescent satellite cells. (A) CSM4B cells were isolated
from the skeletal muscle of 2-mo-old mice. RT-PCR analysis of gene
expression in either freshly isolated CSM4B cells or in cells cultured
for designated days in vitro is displayed. (B–E) Id3 protein is ap-
parent in satellite cells. Myoﬁbers (and associated satellite cells)
were isolated and immunostained with anti-Pax7 and anti-Id3.
Pax7, Id3 satellite cell nucleus is indicated by the arrow. Al-
though Id3 staining in the nucleus is speciﬁc (and conﬁned to the
Pax7 nucleus; arrow), apparent Id3 staining in the myotube is due
to autoﬂuorescence.
Figure 2. Id2 and Id3 are induced in serum-starved C2C12 cells by
either Pax3 or Pax7. (A) RT-PCR analysis of gene expression in
either parental C2C12 cells (control) or in C2C12 polyclones express-
ing exogenous Pax3-HA or Pax7-HA. Cells were either cultured in
10% fetal calf serum (high serum) or in 2% horse serum (low serum)
for 3 d. (B–W) Immunostaining for Id3 or Pax3/7-HA expression in
either parental C2C12 cells or C2C12 polyclones expressing exoge-
nous Pax3-HA or Pax7-HA, grown in either high or low serum
conditions.
D. Kumar et al.
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whereas the expression of these genes was maintained in the
C2C12 polyclones programmed to express either Pax3 or
Pax7 (Figure 2A, lanes 4–6).
Consistent with our analysis of Id3 transcript levels, we
found that Id3 protein is apparent in discrete nuclear inclu-
sions in proliferating C2C12 cells (Figure 2B), but it is not
observed in quiescent C2C12 cells cultured in low serum
conditions (Figure 2E). These ﬁndings are consistent with
prior work indicating that Id family members are speciﬁ-
cally expressed in proliferating cells and are down-regulated
during the process of skeletal muscle differentiation and cell
cycle withdrawal (Benezra et al., 1990). In contrast to the
parental C2C12 cells, where Id3 only accumulates in divid-
ing cells, Id3 protein is apparent both throughout the nu-
cleus and in nuclear inclusions in C2C12 polyclones express-
ing either exogenous Pax3 or Pax7 in high serum and at
slightly attenuated levels in low serum conditions (Figure 2,
I, M, Q, and U). These ﬁndings indicate that Pax3 or Pax7
can induce the expression of Id2 and Id3 speciﬁcally in cells
that are cultured under low serum conditions. To evaluate
whether Id3 protein accumulates in quiescent satellite cells,
we immunostained freshly dissected myoﬁbers with their
associated satellite cells for both Pax7 and Id3. Id3 protein
was speciﬁcally detected in Pax7-expressing quiescent sat-
ellite cells located on the periphery of the myoﬁber (Figure 1,
B–E). These data are consistent with the high level of expres-
sion of Id3 transcripts that are detectable in CSM4B cells
isolated by FACS (Figure 1A, lane 1).
Pax7/Pax3 Can Bind to the Id3 Promoter and Induce the
Transcriptional Activity of an Id3 Luciferase Reporter
To examine whether Id3 is directly regulated by Pax3 or
Pax7, we analyzed the proximal promoter of the mouse Id3
gene for putative PD and HD binding sites. Interestingly, we
identiﬁed putative PD and HD binding sites upstream of the
Id3 proximal promoter in several mammalian species, in-
cluding mouse, rat, human, orangutan, dog, and horse (Fig-
ure 3A). To determine whether Pax3/7 bind to Id3 regula-
tory sequences, we monitored whether Pax3/7 present in
nuclear extracts made from C2C12 cells programmed to
Figure 3. A conserved Pax3/7 binding site is
present upstream of the Id3 promoter. (A)
Conserved HD and PD binding sites are
present upstream of the Id3 promoter in sev-
eral organisms. (B) EMSA using an oligo en-
coding the HD/PD binding sites upstream of
the mouse Id3 gene with nuclear extracts
made from parental C2C12 cells or polyclones
expressing Pax3-FLAG or Pax7-FLAG. Anti-
Pax3, anti-Pax7, anti-FLAG, or anti-tubulin
were added to the EMSA as indicated. Pax3/7
gel shift is indicated by the black arrow; anti-
body supershift is indicated by the white arrow.
(C) Serum factors affect Pax3 or Pax7 mediated
induction of the Id3 reporter. C2C12 cells were
cotransfected with pGL3-Id3(934)-ﬁreﬂy lucif-
erase and pSV40-Renilla-luciferase. In addition,
the cells were cotransfected with either Pax3 or
Pax7 expression vectors, as indicated, and
grown in presence of either high or low serum.
The relative luciferase units (RLU) of pGL3-Id3-
ﬁreﬂy luciferase and pSV40-Renilla-luciferase
are displayed. (D) Pax3 and Pax7 induction of
an Id3 reporter requires both HD and PD bind-
ing sites in the Id3 promoter. C2C12 cells were
cotransfected with either pGL3-Id3(934)-ﬁre-
ﬂy luciferase (containing the wild-type Id3 pro-
moter) or mutated versions of this reporter lack-
ing HD and PD binding sites as shown, plus
pSV40-Renilla-luciferase. In addition, the cells
were cotransfected with expression vehicles en-
coding either Pax3 or Pax7, as indicated. The
RLUs of pGL3-Id3-ﬁreﬂy luciferase and pSV40-
Renilla-luciferase is displayed.
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nucleotide containing the putative Pax3/7 binding site lo-
cated upstream of the Id3 promoter. Nuclear extracts de-
rived from either parental C2C12 cells or such cells infected
with a retrovirus encoding either Pax3-FLAG or Pax7-FLAG
were incubated with a radiolabeled oligomer containing the
putative Pax3/7 binding site in the Id3 promoter (Figure 3B).
The Pax3/7-DNA protein complexes were visualized by
EMSA. Nuclear extracts derived from C2C12 cells pro-
grammed to express either FLAG-tagged Pax3 or FLAG-
tagged Pax7 gave rise to a new DNA–protein complex on
the Id3 oligo (Figure 3B, lanes 3 and 7, black arrow desig-
nates new gel shift) that was not present in extracts derived
from parental C2C12 cells (Figure 3B, lane 2). Importantly,
these DNA–protein complexes were shifted to a lower elec-
trophoretic mobility by inclusion of either anti-Pax3, anti-
Pax7, or anti-FLAG antibodies (Figure 3B, lanes 4, 5, 8, and
9; hollow arrow designates antibody supershifted complex).
In contrast, a control anti-tubulin antibody did not affect the
mobility of the Pax3/7-DNA complexes (Figure 3B, lanes 6
and 10). These ﬁndings indicate that Pax3 and Pax7 can bind
to a conserved sequence located just upstream of the Id3
promoter in vitro.
To evaluate the importance of the putative Pax3/7 bind-
ing site located upstream of the Id3 promoter, we con-
structed a reporter vehicle containing 934 base pairs up-
stream of the Id3 transcriptional initiation site (934 to 13)
driving expression of ﬁreﬂy luciferase (Yeh and Lim, 2000).
Forced expression of either Pax3 or Pax7 in C2C12 cells
cotransfected with this Id3-luciferase reporter, resulted in an
8- to 10-fold increase in luciferase activity, indicating that
both Pax3 and Pax7 can induce expression of a reporter
driven by the Id3 promoter (Figure 3C). Because we noted
that Id3 protein was decreased in C2C12 cells programmed
to express either Pax3 or Pax7 in low serum conditions
(Figure 2, 1, M, Q, and U), we evaluated whether serum
factors would inﬂuence the ability of either Pax3 or Pax7 to
induce expression of the Id3-luciferase reporter. Induction of
the Id3 reporter by either Pax3 or Pax7 was greatest in high
serum conditions (Figure 3C), suggesting that serum factors
may indeed enhance the ability of these transcription factors
to induce maximal Id3 expression. To investigate whether
either the PD or HD binding sites were necessary for Pax3/7
to induce the expression of the Id3 reporter, we mutated
these binding sites individually or in combination. Mutation
of only the PD binding site resulted in about a 50% reduction
in the expression of the Id3 reporter in response to either
cotransfected Pax3 or Pax7, whereas mutation or deletion of
both the PD and HD binding sites resulted in approximately
an 80% reduction in the induction of this reporter by Pax3/
Pax7 (Figure 3D).
Pax7 Binds to the Id3 Promoter in Quiescent Satellite
Cells
To evaluate whether Pax3/7 can bind to the Id3 promoter in
vivo, we performed chromatin immunoprecipitation (IP)
analysis with either parental C2C12 cells or C2C12 poly-
clones programmed to express either exogenous Pax3 or
Pax7. Cells were cultured under low serum conditions, to
stimulate Pax3/7-dependent induction of Id3 expression.
After treatment of the cells with formaldehyde, chromatin
was isolated, sheared by sonication, and regions of the ge-
nome bound by either Pax3 or Pax7 were immunoprecipi-
tated. Both anti-Pax3 and anti-Pax7 antibodies precipitated
chromatin encoding the Pax binding site located upstream of
the Id3 transcription start site in C2C12 cells programmed to
express either exogenous Pax3 or Pax7, respectively (Figure
4B). In contrast these antibodies did not precipitate the Id3
promoter in parental C2C12 cells (Figure 4B), which do not
express detectable levels of Pax3 or Pax7 (Figure 2A).
To investigate whether endogenous Pax7 was similarly
bound upstream of the Id3 promoter in quiescent satellite
cells, we used FACS to isolate CSM4B cells fresh from the
skeletal muscle of 2-mo-old mice. As stated, these cells have
been documented to robustly differentiate into skeletal mus-
cle both in vitro and in vivo, and to engraft into the satellite
cell niche after intramuscular transplant (Cerletti et al., 2008).
Figure 4. Pax7 is bound to the Id3 promoter
in quiescent satellite cells. (A) Diagram of the
Id3 promoter showing location of conserved
HD and PD binding sites. (B) Chromatin IP
with either parental C2C12 cells or C2C12
polyclones expressing either Pax3 or Pax7, in-
dicate that exogenous Pax3 or Pax7 is bound
to the Id3 promoter in cells cultured in low
serum conditions. (C) Chromatin IP with
freshly isolated CSM4B cells indicates that
Pax7 is bound to the Id3 promoter in quies-
cent satellite cells. (D) Pax7 knockdown in
CSM4B cells signiﬁcantly decreases Id2 and
Id3 expression. CSM4B cells were infected
with lentivirus expressing either GFP shRNA
or Pax7 shRNA. Pax7, Id2, and Id3 expression
was analyzed by RT-qPCR.
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express high levels of Pax7, whereas 5% express MyoD
(Cerletti et al., 2008), it seems likely that this population of
cells consists predominantly of quiescent satellite cells.
Freshly isolated CSM4B cells, which express high levels of
Id3 (Figure 1A), were puriﬁed and immediately cross-linked
for chromatin IP analysis. Notably anti-Pax7 was able to
immunoprecipitate chromatin encoding the Pax binding site
located upstream of the Id3 promoter in these freshly iso-
lated Pax7 satellite cells (Figure 4C).
shRNA-mediated Knockdown of Pax7 Expression in
Satellite Cells Signiﬁcantly Reduces the Expression of Id2
and Id3
To examine whether Pax7 was necessary to maintain the
expression of either Id2 or Id3 in satellite cells, we infected
CSM4B cells, isolated from skeletal muscle tissue, with len-
tiviruses programmed to express shRNAs directed against
either green ﬂuorescent protein (shGFP; as a control) or Pax7
(shPax7). Four days after infection, RNA was isolated from
the infected CSM4B cells, and RT-qPCR was used to assay
gene expression. Expression of Pax7 was reduced to 40% of
control levels in cells expressing Pax7 shRNA (Figure 4D).
Notably, the expression of Id2 and Id3 was similarly re-
duced to 61 and 52% of control levels, respectively, in cells
expressing Pax7 shRNA (Figure 4D). The reduction in ex-
pression of both Id2 and Id3 following knockdown of Pax7
expression suggests that Pax7 is necessary to maintain high
level expression of both Id2 and Id3 in satellite cells.
DISCUSSION
Ectopic expression of either Pax3 or Pax7 in C2C12 cells led
to the induction of Id1, Id2, and Id3, speciﬁcally when these
cells were cultured under low serum conditions. Although
these genes are both expressed in proliferating C2C12 cells
grown in 10% fetal bovine serum, their expression is signif-
icantly attenuated when these cells are cultured in low se-
rum conditions (2% horse serum) for 3 d. In striking contrast,
in C2C12 cells programmed to express either exogenous Pax3
or Pax7, expression of these genes is maintained in low
serum-containing medium. Although the Id genes have pre-
viously been linked to cellular proliferation in at least some
cellular contexts (Benezra et al., 1990), in satellite cells Id2
and Id3 are expressed in both quiescent and proliferating
cells, indicating that their expression can be uncoupled from
the cell cycle in this cell type. shRNA-mediated knockdown
of Pax7 expression in puriﬁed satellite cells leads to a sig-
niﬁcant loss in the expression of both Id2 and Id3 in acti-
vated satellite cells in vitro, suggesting that Pax7 is neces-
sary to maintain high level expression of these Id family
members in satellite cells. Because there are conserved
paired domain and homeodomain binding sites located up-
stream of the mouse, rat, human, orangutan, dog, and horse
Id3 genes, which are necessary for efﬁcient induction of an
Id3-luciferase reporter by either Pax3 or Pax7, we propose
that Id3 is a direct transcriptional target of Pax3/7. Consis-
tent with this notion, we have documented that Pax3 and
Pax7 bind to chromatin containing this region of the Id3
gene in C2C12 cells programmed to express either Pax3 or
Pax7 and that endogenous Pax7 is similarly bound to this
region of the Id3 gene in quiescent satellite cells. Together,
our ﬁndings suggest that Id2 and Id3 are transcriptional
targets of Pax7 in satellite cells.
Previous work has indicated that 90% of CSM4B cells
isolated from skeletal muscle express Pax7 and that such
cells exhibit the functional characteristics of quiescent skel-
etal muscle stem cells or satellite cells (Cerletti et al., 2008).
When freshly isolated, this cell population displays robust
expression of Pax7, Myf5, and both Id2 and Id3, yet it does
not express appreciable levels of Id1. Culturing these cells in
vitro leads to both their entry into the cell cycle (Cerletti et
al., 2008), induction of MyoD expression, and subsequent
loss of Pax7 expression (Figure 1A). The expression of Id2
and Id3 eventually declines in these cultures as well, in
parallel with loss of Pax7 expression and induction of skel-
etal muscle differentiation. Previous work has indicated that
expression of Id1 is high in proliferating C2C12 cells and
signiﬁcantly decreases when these cells are induced to dif-
ferentiate in low serum-containing medium (Benezra et al.,
1990). The induction of Id genes by Pax3/Pax7 in C2C12
cells cultured in low serum, or expression of Id2 and Id3 in
quiescent satellite cells, suggests that the expression of Id
factors can be divorced from cellular proliferation. Interest-
ingly, however, maximal induction of the Id3-luciferase re-
porter by cotransfected Pax3/7 required the presence of
high serum.
Chromatin IP analysis demonstrated that Pax7 binds to a
conserved binding site adjacent to the promoter of the Id3
gene in freshly isolated, quiescent satellite cells, and mu-
tagenesis of the Id3 promoter has indicated that this Pax7
binding site is necessary for Pax7-mediated induction of an
Id3-promoter-luciferase construct in transfected C2C12 cells.
Based upon these ﬁndings, we propose that Pax7 may act to
maintain the expression of Id3 (and potentially Id2) specif-
ically in quiescent satellite cells (outlined in Figure 5). Once
satellite cells are induced to enter the cell cycle and express
MyoD, expression of Id2/3 may be maintained either by
signaling pathways downstream of serum factors and/or by
Pax7 that is also expressed in proliferating satellite cells.
Indeed knockdown of Pax7 attenuated the expression of
both Id2 and Id3 in cultures of proliferating satellite cells.
Consistent with the notion that Pax7 may be necessary to
maintain the expression of Id2/3 in growth arrested cells,
expression of both Pax7 and Id2/3 is lost in differentiated
myotubes.
The Id family of HLH proteins have been demonstrated to
block the function of bHLH proteins such as MyoD and
Myf5, by titrating their E protein binding partners (Benezra
et al., 1990); and to also block negative autoregulation of the
Notch effector Hes1 (Bai et al., 2007) and thereby maintain
high level expression of Hes1 and potentially other members
of the hairy/enhancer of split family. In this light, it is
interesting that quiescent satellite cells express relatively
robust levels of both Id2 and Id3 (this study) and several
Figure 5. Pax7 activates the expression of Id2 and Id3 in quiescent
satellite cells. Based on our ﬁndings we speculate that Pax7 induces
the expression of Id2/3 in quiescent satellite cells, where these
dominant-negative HLH factors may act to block premature differ-
entiation of these cells. In activated satellite cells, Pax7 may induce
the expression of both Id2/3 and MyoD/Myf5 before differentia-
tion. In differentiated myotubes, MyoD/Myf5 represses expression
of Pax7 and as a consequence Id2/3 expression is lost.
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Heyl (Fukada et al., 2007), Hes1 and Hey1 (Wagers, unpub-
lished observations). It is possible that high-level expression
of Id2 and Id3 in quiescent satellite cells acts to either block
the activity of Myf5 that is readily expressed (at least at the
RNA level) in at least 90% of quiescent satellite cells (Kuang
et al., 2007) or to maintain the expression of the Notch-
induced transcriptional repressors Hes1, Hey1, and/or
Heyl, which in turn may block expression of MyoD and
Myf5. Thus, by inducing the expression of Id2 and Id3, Pax7
may act to block the premature differentiation of quiescent
satellite cells. In addition, Pax7 may also block skeletal mus-
cle differentiation by targeting myogenic bHLH proteins for
degradation (Olguin et al., 2007). In contrast, in activated
satellite cells, Pax7 may act to directly induce the expression
of Myf5 (Bajard et al., 2006) and MyoD (Hu et al., 2008),
which in turn will compete with Id proteins for E protein
dimerization. In this scenario, Pax7 serves two roles in sat-
ellite cells: blocking their differentiation via Id2/3 induction
during quiescence and promoting their differentiation via
Myf5/MyoD induction during activation (Figure 5). Inter-
estingly, Id family members have been implicated in both
promoting self-renewal and blocking differentiation of he-
matopoietic (Jankovic et al., 2007) and neural (Robert Ben-
ezra, personal communication) stem cells, and our work
suggests that they may play a similar role in satellite cells as
well. Although mice deleted for Id3 are viable and show no
discernible muscle phenotype (Pan et al., 1999), mice lacking
both Id2 and Id3 are embryonic lethal (Robert Benezra,
personal communication). Because quiescent satellite cells
express both Id2 and Id3 (Figure 1), it is possible that the
lack of a skeletal muscle phenotype in mice lacking only Id3
(Pan et al., 1999) is due to functional redundancy with Id2.
Therefore, to determine whether Id2 and Id3 are indeed
necessary to block differentiation of quiescent satellite cells,
it will be necessary to conditionally delete both these genes
in this cell type.
In addition to Id2 and Id3, we noted that several other
genes induced by Pax7 in C2C12 cells were also speciﬁcally
expressed in quiescent satellite cells. These genes include
ITM2A, the chemokine receptor CXCR4, BMP4, the sugar
binding protein chondrolectin, C1R, PTGIS, and MGP. In-
terestingly, the expression of many of these Pax7 inducible
genes was greatest in quiescent satellite cells and expression
of these genes was extinguished during either proliferation
or differentiation of these cells. CXCR4 has already been
demonstrated to play a crucial role in migration of skeletal
muscle cells during embryogenesis (Vasyutina et al., 2005). It
will be interesting to determine the role of both Id2/Id3 and
these other putative Pax7 transcriptional targets in quiescent
satellite cells.
ACKNOWLEDGMENTS
We thank Robert Lim for generously supplying the Id3 promoter; Michael
Rudnicki for the Pax7 cDNA; Hyung-song Nam, Yvette Chin, and Robert
Benezra for characterizing and supplying the anti-Id3 rabbit monoclonal
antibody (now available from CalBioreagents, San Mateo, CA); and Robert
Benezra for thoughtful comments on our work. This work was funded by
National Institutes of Health grant GM-054879 (to A.B.L.) and grants from the
Harvard Stem Cell Institute, Jain Foundation, and Beckman Foundation (to
A.J.W.). D. K. was funded by a fellowship from the Muscular Dystrophy
Association.
REFERENCES
Attema, J. L., Papathanasiou, P., Forsberg, E. C., Xu, J., Smale, S. T., and
Weissman, I. L. (2007). Epigenetic characterization of hematopoietic stem cell
differentiation using miniChIP and bisulﬁte sequencing analysis. Proc. Natl.
Acad. Sci. USA 104, 12371–12376.
Bai, G., Sheng, N., Xie, Z., Bian, W., Yokota, Y., Benezra, R., Kageyama, R.,
Guillemot, F., and Jing, N. (2007). Id sustains Hes1 expression to inhibit
precocious neurogenesis by releasing negative autoregulation of Hes1. Dev.
Cell 13, 283–297.
Bajard, L., Relaix, F., Lagha, M., Rocancourt, D., Daubas, P., and Buckingham,
M. E. (2006). A novel genetic hierarchy functions during hypaxial myogenesis:
Pax3 directly activates Myf5 in muscle progenitor cells in the limb. Genes
Dev. 20, 2450–2464.
Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L., and Weintraub, H.
(1990). The protein Id: a negative regulator of helix-loop-helix DNA binding
proteins. Cell 61, 49–59.
Cerletti, M., Jurga, S., Witczak, C. A., Hirshman, M. F., Shadrach, J. L.,
Goodyear, L. J., and Wagers, A. J. (2008). Highly efﬁcient, functional engraft-
ment of skeletal muscle stem cells in dystrophic muscles. Cell 134, 37–47.
Chalepakis, G., Goulding, M., Read, A., Strachan, T., and Gruss, P. (1994).
Molecular basis of splotch and Waardenburg Pax-3 mutations. Proc. Natl.
Acad. Sci. USA 91, 3685–3689.
Chalepakis, G., and Gruss, P. (1995). Identiﬁcation of DNA recognition se-
quences for the Pax3 paired domain. Gene 162, 267–270.
Conboy, I. M., and Rando, T. A. (2002). The regulation of Notch signaling
controls satellite cell activation and cell fate determination in postnatal myo-
genesis. Dev. Cell 3, 397–409.
Fukada, S., Uezumi, A., Ikemoto, M., Masuda, S., Segawa, M., Tanimura, N.,
Yamamoto, H., Miyagoe-Suzuki, Y., and Takeda, S. (2007). Molecular signa-
ture of quiescent satellite cells in adult skeletal muscle. Stem Cells 25, 2448–
2459.
Gros, J., Manceau, M., Thome, V., and Marcelle, C. (2005). A common somitic
origin for embryonic muscle progenitors and satellite cells. Nature 435, 954–
958.
Hu, P., Geles, K. G., Paik, J. H., DePinho, R. A., and Tjian, R. (2008). Code-
pendent activators direct myoblast-speciﬁc MyoD transcription. Dev. Cell 15,
534–546.
Jankovic, V., Ciarrocchi, A., Boccuni, P., DeBlasio, T., Benezra, R., and Nimer,
S. D. (2007). Id1 restrains myeloid commitment, maintaining the self-renewal
capacity of hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 104, 1260–
1265.
Kassar-Duchossoy, L., Giacone, E., Gayraud-Morel, B., Jory, A., Gomes, D.,
and Tajbakhsh, S. (2005). Pax3/Pax7 mark a novel population of primitive
myogenic cells during development. Genes Dev. 19, 1426–1431.
Kuang, S., Kuroda, K., Le Grand, F., and Rudnicki, M. A. (2007). Asymmetric
self-renewal and commitment of satellite stem cells in muscle. Cell 129,
999–1010.
Lagha, M., Kormish, J. D., Rocancourt, D., Manceau, M., Epstein, J. A., Zaret,
K. S., Relaix, F., and Buckingham, M. E. (2008). Pax3 regulation of FGF
signaling affects the progression of embryonic progenitor cells into the myo-
genic program. Genes Dev. 22, 1828–1837.
Maroto, M., Reshef, R., Munsterberg, A. E., Koester, S., Goulding, M., and
Lassar, A. B. (1997). Ectopic Pax-3 activates MyoD and Myf-5 expression in
embryonic mesoderm and neural tissue. Cell 89, 139–148.
McKinnell, I. W., Ishibashi, J., Le Grand, F., Punch, V. G., Addicks, G. C.,
Greenblatt, J. F., Dilworth, F. J., and Rudnicki, M. A. (2008). Pax7 activates
myogenic genes by recruitment of a histone methyltransferase complex. Nat.
Cell Biol. 10, 77–84.
Montarras, D., Morgan, J., Collins, C., Relaix, F., Zaffran, S., Cumano, A.,
Partridge, T., and Buckingham, M. (2005). Direct isolation of satellite cells for
skeletal muscle regeneration. Science 309, 2064–2067.
Munsterberg, A. E., Kitajewski, J., Bumcrot, D. A., McMahon, A. P., and
Lassar, A. B. (1995). Combinatorial signaling by Sonic hedgehog and Wnt
family members induces myogenic bHLH gene expression in the somite.
Genes Dev. 9, 2911–2922.
Nakatani, Y., and Ogryzko, V. (2003). Immunoafﬁnity puriﬁcation of mam-
malian protein complexes. Methods Enzymol. 370, 430–444.
Olguin, H. C., Yang, Z., Tapscott, S. J., and Olwin, B. B. (2007). Reciprocal
inhibition between Pax7 and muscle regulatory factors modulates myogenic
cell fate determination. J. Cell Biol. 177, 769–779.
Pan, L., Sato, S., Frederick, J. P., Sun, X. H., and Zhuang, Y. (1999). Impaired
immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol.
Cell Biol. 19, 5969–5980.
Perk, J., Iavarone, A., and Benezra, R. (2005). Id family of helix-loop-helix
proteins in cancer. Nat. Rev. Cancer 5, 603–614.
D. Kumar et al.
Molecular Biology of the Cell 3176Relaix, F., Polimeni, M., Rocancourt, D., Ponzetto, C., Schafer, B. W., and
Buckingham, M. (2003). The transcriptional activator PAX3-FKHR rescues the
defects of Pax3 mutant mice but induces a myogenic gain-of-function pheno-
type with ligand-independent activation of Met signaling in vivo. Genes Dev.
17, 2950–2965.
Relaix, F., Rocancourt, D., Mansouri, A., and Buckingham, M. (2004). Divergent
functions of murine Pax3 and Pax7 in limb muscle development. Genes Dev. 18,
1088–1105.
Relaix, F., Rocancourt, D., Mansouri, A., and Buckingham, M. (2005). A Pax3/
Pax7-dependent population of skeletal muscle progenitor cells. Nature 435, 948–953.
Ruzinova, M. B., and Benezra, R. (2003). Id proteins in development, cell cycle
and cancer. Trends Cell Biol. 13, 410–418.
Schienda, J., Engleka, K. A., Jun, S., Hansen, M. S., Epstein, J. A., Tabin, C. J.,
Kunkel, L. M., and Kardon, G. (2006). Somitic origin of limb muscle satellite
and side population cells. Proc. Natl. Acad. Sci. USA 103, 945–950.
Seale, P., Ishibashi, J., Scime, A., and Rudnicki, M. A. (2004). Pax7 is necessary
and sufﬁcient for the myogenic speciﬁcation of CD45:Sca1 stem cells from
injured muscle. PLoS Biol. 2, E130.
Smith, H. K., Maxwell, L., Rodgers, C. D., McKee, N. H., and Plyley, M. J.
(2001). Exercise-enhanced satellite cell proliferation and new myonuclear
accretion in rat skeletal muscle. J. Appl. Physiol. 90, 1407–1414.
Tajbakhsh, S., Rocancourt, D., Cossu, G., and Buckingham, M. (1997). Rede-
ﬁning the genetic hierarchies controlling skeletal myogenesis: Pax-3 and
Myf-5 act upstream of MyoD. Cell 89, 127–138.
Vasyutina, E., Stebler, J., Brand-Saberi, B., Schulz, S., Raz, E., and Birchmeier,
C. (2005). CXCR4 and Gab1 cooperate to control the development of migrat-
ing muscle progenitor cells. Genes Dev. 19, 2187–2198.
Yan, Z., Choi, S., Liu, X., Zhang, M., Schageman, J. J., Lee, S. Y., Hart, R., Lin,
L., Thurmond, F. A., and Williams, R. S. (2003). Highly coordinated gene
regulation in mouse skeletal muscle regeneration. J. Biol. Chem. 278, 8826–
8836.
Yeh, K., and Lim, R. W. (2000). Genomic organization and promoter analysis
of the murine Id3 gene. Gene 254, 163–171.
Zammit, P. S., Partridge, T. A., and Yablonka-Reuveni, Z. (2006). The skeletal
muscle satellite cell: the stem cell that came in from the cold. J. Histochem.
Cytochem. 54, 1177–1191.
Id3 Is a Transcriptional Target of Pax7
Vol. 20, July 15, 2009 3177